APA (7th ed.) Citation

Gutzmer, R., Mohr, P., Kähler, K., Ascierto, P., Scalvenzi, M., Peris, K., . . . Hauschild, A. Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events. Elsevier.

Chicago Style (17th ed.) Citation

Gutzmer, R., et al. Interim Analysis of the Multinational, Post-authorisation Safety Study (NISSO) to Assess the Long-term Safety of Sonidegib in Patients with Locally Advanced Basal Cell Carcinoma: Time to Onset of Adverse Events. Elsevier.

MLA (9th ed.) Citation

Gutzmer, R., et al. Interim Analysis of the Multinational, Post-authorisation Safety Study (NISSO) to Assess the Long-term Safety of Sonidegib in Patients with Locally Advanced Basal Cell Carcinoma: Time to Onset of Adverse Events. Elsevier.